Previously, the presented data showed that MIM1, which possesses the capacity to inhibit Mcl-1 antiapoptotic protein, may be an efficient compound able to induce apoptosis and sensitize melanoma [5, 6] as well as glioblastoma multiforme [7] cells to alkylating chemotherapeutics. This evidence concerns the gene MCL1 and glioblastoma.